Brain HealthPGC-1α Is a Nuanced Brain Health Switch, Not a Simple Neuroprotective Lever
PGC-1α is a master regulator of mitochondrial health, antioxidant defense, and inflammation — all processes that break down in neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS. Researchers hoped boosting PGC-1α would protect neurons, but this review reveals the picture is far more complicated. The protein acts more like a precision dial than an on/off switch: its effects depend on cell type, disease stage, which version of the protein is active, and how strongly it is activated. Broad or poorly timed activation can actually be harmful. Emerging therapies — including small molecules, gene therapy, and nanoparticles — are mostly still in animal models and face serious delivery challenges to the brain. The authors argue that future treatments must target PGC-1α precisely rather than globally.
